The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Celgene; Gilead Sciences; Johnson & Johnson
Research Funding - Celgene; Johnson & Johnson
Travel, Accommodations, Expenses - Johnson & Johnson; Roche Pharma AG
Ibrutinib combined with bendamustine and rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): First results from a randomized, double-blind, placebo-controlled, phase III study.
 
Asher Alban Akmal Chanan-Khan
No Relationships to Disclose
 
Paula Cramer
Speakers' Bureau - Janssen-Cilag; Proacta
Research Funding - Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Proacta
Travel, Accommodations, Expenses - Astellas Pharma
 
Fatih Demirkan
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Celgene
 
Graeme Fraser
Honoraria - Celgene; Janssen; Proacta
Consulting or Advisory Role - Proacta
Speakers' Bureau - Janssen
Research Funding - Celgene; Janssen
 
Rodrigo Santucci Silva
Research Funding - Celgene; GlaxoSmithKline; Janssen; Merck; Roche Pharma AG
Travel, Accommodations, Expenses - Janssen; Novartis; Roche Pharma AG
 
Halyna Pylypenko
No Relationships to Disclose
 
Sebastian Grosicki
No Relationships to Disclose
 
Ann Janssens
Speakers' Bureau - Mundipharma; Roche Pharma AG
 
Alexander Pristupa
No Relationships to Disclose
 
Jiri Mayer
Research Funding - Janssen
 
Marie-Sarah Dilhuydy
Honoraria - Janssen; Roche Pharma AG
 
Javier Loscertales
No Relationships to Disclose
 
Nancy L. Bartlett
Consulting or Advisory Role - Gilead Sciences; Seagen
Research Funding - AstraZeneca (Inst); Celgene (Inst); Genentech (Inst); Inanovate (Inst); Janssen Research & Development (Inst); MedImmune (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Abraham Avigdor
Consulting or Advisory Role - Janssen; Johnson & Johnson
 
Simon Rule
No Relationships to Disclose
 
Steven Sun
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Michelle Mahler
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Mariya Salman
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Angela J. Howes
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Michael J. Hallek
Honoraria - Abbvie; Amgen; Gilead Sciences; Janssen; Mundipharma; Roche Pharma AG
Consulting or Advisory Role - Abbvie; Amgen; Gilead Sciences; Janssen; Mundipharma; Roche Pharma AG
Speakers' Bureau - Amgen; Gilead Sciences; Roche Pharma AG
Research Funding - Gilead Sciences; Janssen; Roche Pharma AG